Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Waibler

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
The Journal of General Virology|October 9, 2009
Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factorNico Buettner, Carola Vogt, Luis Martínez-Sobrido, et al.
Journal of Immunotoxicology|December 10, 2024
Analyzing IL-2-induced vascular leakage with an irAOP as toolPatricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann, et al.
Journal of Virology|September 24, 2010
Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cellsGeorg Kochs, Stefanie Bauer, Carola Vogt, et al.
Journal of Virology|September 15, 2007
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responsesZoe Waibler, Martina Anzaghe, Holger Ludwig, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2019
Individual combinations of danger signals synergistically increase FVIII product immunogenicityLilija Miller, Jessica Klemm, Carolin Schmidt, et al.
Blood|May 12, 2012
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activationSabrina Weissmüller, Linda Y Semmler, Ulrich Kalinke, et al.
Molecular Immunology|January 15, 2010
CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signalsLinda Y Sender, Kathrin Gibbert, Yasemin Suezer, et al.
Journal of Immunotoxicology|December 10, 2024
Revival of recombinant IL-2 therapy - approaches from the past until todayLuise A Roser, Charline Sommer, Samira Ortega Iannazzo, et al.
Molecular Immunology|October 23, 2010
Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DCStefan Schülke, Zoe Waibler, Marc-Stefan Mende, et al.
The Journal of General Virology|July 16, 2021
Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA virusesMartina Anzaghe, Stefanie Kronhart, Marc A Niles, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Journal of General Virology|October 9, 2009
Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factorNico Buettner, Carola Vogt, Luis Martínez-Sobrido, et al.
Journal of Immunotoxicology|December 10, 2024
Analyzing IL-2-induced vascular leakage with an irAOP as toolPatricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann, et al.
Journal of Virology|September 24, 2010
Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cellsGeorg Kochs, Stefanie Bauer, Carola Vogt, et al.
Journal of Virology|September 15, 2007
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responsesZoe Waibler, Martina Anzaghe, Holger Ludwig, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2019
Individual combinations of danger signals synergistically increase FVIII product immunogenicityLilija Miller, Jessica Klemm, Carolin Schmidt, et al.
Blood|May 12, 2012
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activationSabrina Weissmüller, Linda Y Semmler, Ulrich Kalinke, et al.
Molecular Immunology|January 15, 2010
CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signalsLinda Y Sender, Kathrin Gibbert, Yasemin Suezer, et al.
Journal of Immunotoxicology|December 10, 2024
Revival of recombinant IL-2 therapy - approaches from the past until todayLuise A Roser, Charline Sommer, Samira Ortega Iannazzo, et al.
Molecular Immunology|October 23, 2010
Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DCStefan Schülke, Zoe Waibler, Marc-Stefan Mende, et al.
The Journal of General Virology|July 16, 2021
Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA virusesMartina Anzaghe, Stefanie Kronhart, Marc A Niles, et al.
Pageof 6